Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Laparoscopic appendectomy outcomes on the weekend and during the week are no different: a national study of 151,774 patients
Worni M, Østbye T, Gandhi M, Rajgor D, Shah J, Shah A, Pietrobon R, Jacobs D, Gueller U. Laparoscopic appendectomy outcomes on the weekend and during the week are no different: a national study of 151,774 patients. World J Surg 2012; 36:1527-33.
01.07.2012Laparoscopic appendectomy outcomes on the weekend and during the week are no different: a national study of 151,774 patients
01.07.2012World J Surg 2012; 36:1527-33
Worni Mathias, Østbye Truls, Gandhi Mihir, Rajgor Dimple, Shah Jatin, Shah Anand, Pietrobon Ricardo, Jacobs Danny O, Gueller Ulrich
Worse outcomes in patients undergoing urgent surgery for left-sided diverticulitis admitted on weekends vs weekdays: a population-based study of 31 832 patients
Worni M, Schudel I, Østbye T, Shah A, Khare A, Pietrobon R, Thacker J, Gueller U. Worse outcomes in patients undergoing urgent surgery for left-sided diverticulitis admitted on weekends vs weekdays: a population-based study of 31 832 patients. Arch Surg 2012; 147:649-55.
01.07.2012Worse outcomes in patients undergoing urgent surgery for left-sided diverticulitis admitted on weekends vs weekdays: a population-based study of 31 832 patients
01.07.2012Arch Surg 2012; 147:649-55
Worni Mathias, Schudel Inge M, Østbye Truls, Shah Anand, Khare Aarti, Pietrobon Ricardo, Thacker Julie K Marosky, Gueller Ulrich
Systemic therapy of neuroendocrine tumors of the lung
Siano M. Systemic therapy of neuroendocrine tumors of the lung - Review. Lung Cancer Management 2012; 1:1-8.
01.07.2012Systemic therapy of neuroendocrine tumors of the lung
01.07.2012Lung Cancer Management 2012; 1:1-8
Siano Marco
Diabetesscreening 2011: Wie gut werden die Empfehlungen in der Praxis umgesetzt?
Saxer H, Rautenberg O, Fehr M, Lachat R, Eggimann T, Brühwiler H (2012). Diabetesscreening 2011: Wie gut werden die Empfehlungen in der Praxis umgesetzt?. Präsentiert bei: Jahreskongress SGGG, Interlaken
28.06.2012Diabetesscreening 2011: Wie gut werden die Empfehlungen in der Praxis umgesetzt?
28.06.2012Jahreskongress SGGG
Saxer Helene, Rautenberg Oliver, Fehr M, Lachat R, Eggimann T, Brühwiler H
Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients
Tarantino I, Cerny T, Steffen T, Mueller S, Schmied B, Köberle D, Merati-Kashani K, Worni M, Warschkow R, Gueller U. Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer 2012; 107:266-74.
26.06.2012Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients
26.06.2012Br J Cancer 2012; 107:266-74
Tarantino Ignazio, Cerny Thomas, Steffen Thomas, Mueller Sascha, Schmied B M, Köberle Dieter, Merati-Kashani K, Worni M, Warschkow Rene, Gueller Ulrich
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
Huober J, Regan M, Gelber R, Price K, Öhlschlegel C, Viale G, Coates A, Goldhirsch A, Gelber S, Thürlimann B. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol 2012; 23:2843-51.
14.06.2012Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
14.06.2012Ann Oncol 2012; 23:2843-51
Huober Jens, Regan M M, Gelber R D, Price K N, Öhlschlegel Christian, Viale G, Coates A S, Goldhirsch A, Gelber S, Thürlimann Beat
Follow up after IMRT in oral cavity cancer: update.
Studer G, Brown M, Bredell M, Graetz K, Huber G, Linsenmeier C, Najafi Y, Riesterer O, Rordorf T, Schmid S, Glanzmann C. Follow up after IMRT in oral cavity cancer: update. Radiat Oncol 2012; 7:84.
11.06.2012Follow up after IMRT in oral cavity cancer: update.
11.06.2012Radiat Oncol 2012; 7:84
Studer Gabriela, Brown Michelle L, Bredell Marius, Graetz Klaus W, Huber Gerhard, Linsenmeier Claudia, Najafi Yousef, Riesterer Oliver, Rordorf Tamara, Schmid Stephan, Glanzmann Christoph
Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?
Gueller U, Zettl A, Worni M, Langer I, Cabalzar-Wondberg D, Viehl C, Demartines N, Zuber M. Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?. Cancer 2012; 118:6039-45.
08.06.2012Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?
08.06.2012Cancer 2012; 118:6039-45
Gueller Ulrich, Zettl Andreas, Worni Mathias, Langer Igor, Cabalzar-Wondberg Daniela, Viehl Carsten T, Demartines Nicolas, Zuber Markus
Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques
Schoenewolf N, von Moos R, Schraml P, Gillessen Sommer S, Ochsenbein A, Simcock M, Moch H, Mihic-Probst D, Dummer R, Swiss Group for Clinical Cancer Research (SAKK). Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques. Case Rep Oncol 2012; 5:280-9.
05.06.2012Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques
05.06.2012Case Rep Oncol 2012; 5:280-9
Schoenewolf Nicola L, von Moos Roger, Schraml Peter, Gillessen Sommer Silke, Ochsenbein Adrian, Simcock Mathew, Moch Holger, Mihic-Probst Daniela, Dummer Reinhard, Swiss Group for Clinical Cancer Research (SAKK)
A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma
Stenner F, Renner C, Porta C, Buchler T, Knuth A, Stoll S, Siciliano R, Rothermundt C, Cathomas R, Haile S, Liewen H, Chastonay R, Samaras P. A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma. Oncology 2012; 82:333-340.
02.06.2012A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma
02.06.2012Oncology 2012; 82:333-340
Stenner Frank, Renner Christoph, Porta Camillo, Buchler Tomas, Knuth Alexander, Stoll Susanna, Siciliano Raffaele D, Rothermundt Christian, Cathomas Richard, Haile Sarah R, Liewen Heike, Chastonay Rahel, Samaras Panagiotis
Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis
Jörger M, Wilkins J, Fagagnini S, Baldinger R, Brenneisen R, Schneider U, Goldman B, Weber M. Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis. Drug Metab Lett 2012; 6:102-8.
01.06.2012Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis
01.06.2012Drug Metab Lett 2012; 6:102-8
Jörger Markus, Wilkins Justin, Fagagnini Stefania, Baldinger Reto, Brenneisen Rudolf, Schneider Ursula, Goldman Bea, Weber Markus
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)
Früh M, Pless M, Fustier P, Küttel E, Simcock M, Rauch D, Krasniqi F, Erdmann A, Mamot C, Zippelius A, Tscherry G, Siano M, Cathomas R, Swiss Group for Clinical Cancer Research. Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08). Clin Lung Cancer 2012; 14:34-9.
24.05.2012Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)
24.05.2012Clin Lung Cancer 2012; 14:34-9
Früh Martin, Pless Miklos, Fustier Pierre, Küttel Erika, Simcock Mathew, Rauch Daniel, Krasniqi Fatima, Erdmann Andreas, Mamot Christoph, Zippelius Alfred, Tscherry Gregor, Siano Marco, Cathomas Richard, Swiss Group for Clinical Cancer Research
Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma
Jörger M, Huitema A, Illerhaus G, Ferreri A. Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma. Leuk Lymphoma 2012; 53:1867-75.
21.05.2012Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma
21.05.2012Leuk Lymphoma 2012; 53:1867-75
Jörger Markus, Huitema A D R, Illerhaus G, Ferreri A J M
VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5
Herr D, Sallmann A, Bekes I, Konrad R, Holzheu I, Kreienberg R, Wulff C. VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5. Gynecol Oncol 2012; 127:210-6.
08.05.2012VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5
08.05.2012Gynecol Oncol 2012; 127:210-6
Herr Daniel, Sallmann Alexandra, Bekes Inga, Konrad Regina, Holzheu Iris, Kreienberg Rolf, Wulff Christine
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV
Meier W, Burges A, Stähle A, Belau A, Schröder W, Richter B, Wimberger P, Schmalfeldt B, Canzler U, Kreienberg R, Wollschlaeger K, Huober J, Baumann K, Gropp-Meier M, Rau J, du Bois A, Sehouli J. Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV. Gynecol Oncol 2012; 126:236-40.
04.05.2012Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV
04.05.2012Gynecol Oncol 2012; 126:236-40
Meier Werner, Burges Alexander, Stähle Anne, Belau Antje, Schröder Willibald, Richter Barbara, Wimberger Pauline, Schmalfeldt Barbara, Canzler Ulrich, Kreienberg Rolf, Wollschlaeger Kerstin, Huober Jens, Baumann Klaus, Gropp-Meier Martina, Rau Jörn, du Bois Andreas, Sehouli Jalid
DESO St. Gallen, 2012: die Therapie des metastasierten Weichteilsarkoms im Erwachsenenalter
Rothermundt C, Putora P. DESO St. Gallen, 2012: die Therapie des metastasierten Weichteilsarkoms im Erwachsenenalter. Leading Opinions Hämatologie / Onkologie 2012; 2012:1-5.
03.05.2012DESO St. Gallen, 2012: die Therapie des metastasierten Weichteilsarkoms im Erwachsenenalter
03.05.2012Leading Opinions Hämatologie / Onkologie 2012; 2012:1-5
Rothermundt Christian, Putora Paul Martin
Palliative Systemtherapie des metastasierten Weichteil-Sarkoms
Cerny T, Rothermundt C, Putora P. Palliative Systemtherapie des metastasierten Weichteil-Sarkoms. info@onkologie 2012; 2012:6-9.
27.04.2012Palliative Systemtherapie des metastasierten Weichteil-Sarkoms
27.04.2012info@onkologie 2012; 2012:6-9
Cerny Thomas, Rothermundt Christian, Putora Paul Martin
Interdisziplinäre Therapie der Extremitäten-Weichteil-Sarkome
Keller S, Putora P, Rothermundt C. Interdisziplinäre Therapie der Extremitäten-Weichteil-Sarkome. info@onkologie 2012; 2012:10-13.
27.04.2012Interdisziplinäre Therapie der Extremitäten-Weichteil-Sarkome
27.04.2012info@onkologie 2012; 2012:10-13
Keller Stephan, Putora Paul Martin, Rothermundt Christian
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
Ribi K, BIG 1-98 Collaborative Group, Bernhard J, Gelber R, Price K, Goldhirsch A, Coates A, Pagani O, Cardoso F, Thürlimann B, Harvey V, Thompson A, Phillips K, Aldridge J, International Breast Cancer Study Group. Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. Br J Cancer 2012; 106:1618-25.
24.04.2012Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
24.04.2012Br J Cancer 2012; 106:1618-25
Ribi K, BIG 1-98 Collaborative Group, Bernhard J, Gelber R D, Price K N, Goldhirsch A, Coates A S, Pagani O, Cardoso F, Thürlimann Beat, Harvey V, Thompson A, Phillips K-A, Aldridge J, International Breast Cancer Study Group
Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome
Klass N, Aebersold D, Krause T, Plasswilm L, Blumstein N, Born E, Cihoric N, Schmidhalter D, Früh M, Malthaner M, Toepfer M, Klaeser B, Schmuecking M (2012). Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome.
19.04.2012Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome
19.04.2012SASRO 2012
Klass ND, Aebersold D, Krause T, Plasswilm Ludwig, Blumstein N, Born E, Cihoric N, Schmidhalter D, Früh Martin, Malthaner M, Toepfer Michael, Klaeser B, Schmuecking M